Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 26,290	$ 13,787	$ 71,671	$ 38,019
General and administrative	6,756	4,881	19,685	13,495
Total operating expenses	33,046	18,668	91,356	51,514
Loss from operations	(33,046)	(18,668)	(91,356)	(51,514)
Other income:
Interest income	2,417	2,220	8,078	4,725
Net loss	(30,629)	(16,448)	(83,278)	(46,789)
Other comprehensive income:
Net unrealized gain (loss) on available-for-sale investments, net of tax	30	(18)	(38)	(21)
Net comprehensive loss	$ (30,599)	$ (16,466)	$ (83,316)	$ (46,810)
Net loss per share of voting and non-voting common stock, basic	$ (0.62)	$ (0.37)	$ (1.69)	$ (1.18)
Net loss per share of voting and non-voting common stock, diluted	$ (0.62)	$ (0.37)	$ (1.69)	$ (1.18)